HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients

Complete list of metadata

https://hal.univ-brest.fr/hal-02055852
Contributor : Ghislaine Calvez Connect in order to contact the contributor
Submitted on : Monday, March 4, 2019 - 12:12:42 PM
Last modification on : Tuesday, April 26, 2022 - 4:26:11 PM

Identifiers

  • HAL Id : hal-02055852, version 1

Citation

Jean-Guillaume Dillinger, Boris Aleil, Saida Cheggour, Ygal Benhamou, Yannick Béjot, et al.. Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients. Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2018, 111 (2), pp.85-94. ⟨hal-02055852⟩

Share

Metrics

Record views

34